Tuba ÇANDAR, Zekiye HASBEK, Gülhan DUMAN, Seyit Ahmet ERTÜRK, Ali ÇAKMAKCILAR

SERUM GALEKTİN-3 VE DİFERANSİYE TİROİD KANSER İLİŞKİSİ The Relation Between Serum Galectin-3 and Differential Thyroid Cancers

Anahtar Kelimeler:

SERUM GALEKTİN-3 VE DİFERANSİYE TİROİD KANSER İLİŞKİSİ The Relation Between Serum Galectin-3 and Differential Thyroid Cancers

PDF

___

1. R. Görges. The Changing Epidemiology of Thyroid Cancer. In: H.-J. Biersack F. Grünwald, Eds. Thyroid Cancer. Springer Science+Business Media, Germany, 2005.p:3-21. 2. Fernández PL, Merino MJ, Gómez M, Campo E, Medina T, Castronovo V, Sanjuán X, Cardesa A, Liu FT, Sobel ME. Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue. J Pathol. 1997;181(1):80-6. 3. Liu Z, Li X, Shi L, Maimaiti Y, Chen T, Li Z, Wang S, Xiong Y, Guo H, He W, Liu C, Nie X, Zeng W, Huang T. Cytokeratin 19, thyroperoxidase, HBME-1 and Galectin-3 in evaluation of aggressive behavior of papillary thyroid carcinoma. Int J Clin Exp Med. 2014,15;7(8):2304-8. 4. Maruta J, Hashimoto H, Yamashita H, Yamashita H, Noguchi S. Immunostaining of Galectin-3 and CD44v6 using fine-needle aspiration for distinguishing follicular carcinoma from adenoma. Diagn Cytopathol. 2004;31(6):392-6. 5. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1-133. 6. Yılmaz E, Karşıdağ T, Tatar C, Tüzün S. Serum Galectin-3: diagnostic value for papillary thyroid carcinoma. Ulus Cerrahi Derg. 2015, 9;31(4):192-6. 7. Kovács RB, Földes J, Winkler G, Bodó M, Sápi Z. The investigation of Galectin-3 in diseases of the thyroid gland. Eur J Endocrinol. 2003;149(5):449-53. 8. Al-Sharaky DR, Younes SF. Sensitivity and Specificity of Galectin-3 and Glypican-3 in Follicular-Patterned and Other Thyroid Neoplasms. J Clin Diagn Res. 2016;10(3):EC06-10. 9. Selemetjev SA, Savin SB, Paunovic IR, Tatic SB, Cvejic D. Changes in the expression pattern of apoptotic molecules (Galectin-3, Bcl-2,Bax, survivin) during progression of thyroid malignancy and their clinical significance. Wien Klin Wochenschr. 2015;127(9-10):337-44. 10. Türköz HK, Oksüz H, Yurdakul Z, Ozcan D. Galectin-3 expression in tumor progression and metastasis of papillary thyroid carcinoma. Endocr Pathol. 2008;19(2):92-6.